Beasley G - Search Results

1

Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).

Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS. Broman KK, et al. Among authors: beasley g. Cancer. 2021 Jul 1;127(13):2251-2261. doi: 10.1002/cncr.33483. Epub 2021 Apr 7. Cancer. 2021. PMID: 33826754 Free PMC article.

2

A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.

Beasley GM, Caudle A, Petersen RP, McMahon NS, Padussis J, Mosca PJ, Zager JS, Hochwald SN, Grobmyer SR, Delman KA, Andtbacka RH, Noyes RD, Kane JM, Seigler H, Pruitt SK, Ross MI, Tyler DS. Beasley GM, et al. J Am Coll Surg. 2009 May;208(5):706-15; discussion 715-7. doi: 10.1016/j.jamcollsurg.2008.12.019. Epub 2009 Mar 26. J Am Coll Surg. 2009. PMID: 19476821

3

Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.

Santillan AA, Delman KA, Beasley GM, Mosca PJ, Hochwald SN, Grobmyer SR, Andtbacka RH, Noyes RD, Kane JM, Ross MI, Tyler DS, Zager JS. Santillan AA, et al. Ann Surg Oncol. 2009 Sep;16(9):2570-8. doi: 10.1245/s10434-009-0563-9. Epub 2009 Jun 19. Ann Surg Oncol. 2009. PMID: 19543771

4

A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.

Beasley GM, McMahon N, Sanders G, Augustine CK, Selim MA, Peterson B, Norris R, Peters WP, Ross MI, Tyler DS. Beasley GM, et al. Cancer. 2009 Oct 15;115(20):4766-74. doi: 10.1002/cncr.24509. Cancer. 2009. PMID: 19637344 Free PMC article. Clinical Trial.

5

Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma.

Beasley GM, Riboh JC, Augustine CK, Zager JS, Hochwald SN, Grobmyer SR, Peterson B, Royal R, Ross MI, Tyler DS. Beasley GM, et al. J Clin Oncol. 2011 Mar 20;29(9):1210-5. doi: 10.1200/JCO.2010.32.1224. Epub 2011 Feb 22. J Clin Oncol. 2011. PMID: 21343562 Free PMC article. Clinical Trial.

6

Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms.

Turaga KK, Beasley GM, Kane JM 3rd, Delman KA, Grobmyer SR, Gonzalez RJ, Letson GD, Cheong D, Tyler DS, Zager JS. Turaga KK, et al. Among authors: beasley gm. Arch Surg. 2011 Jul;146(7):870-5. doi: 10.1001/archsurg.2011.139. Arch Surg. 2011. PMID: 21768436 Free PMC article.

7

Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion.

Han D, Beasley GM, Tyler DS, Zager JS. Han D, et al. Expert Opin Drug Metab Toxicol. 2011 Nov;7(11):1383-94. doi: 10.1517/17425255.2011.609555. Epub 2011 Oct 7. Expert Opin Drug Metab Toxicol. 2011. PMID: 21978383 Free PMC article. Review.

8

A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities.

Chai CY, Deneve JL, Beasley GM, Marzban SS, Chen YA, Rawal B, Grobmyer SR, Hochwald SN, Tyler DS, Zager JS. Chai CY, et al. Ann Surg Oncol. 2012 May;19(5):1637-43. doi: 10.1245/s10434-011-2151-z. Epub 2011 Dec 6. Ann Surg Oncol. 2012. PMID: 22143576 Free PMC article.

9

A multi-institution experience comparing the clinical and physiologic differences between upper extremity and lower extremity melphalan-based isolated limb infusion.

Beasley GM, Sharma K, Wong J, Miller M, Turley RS, Lidsky M, Masoud M, Dewhirst MW, Mosca PJ, Zager JS, Tyler DS. Beasley GM, et al. Cancer. 2012 Dec 15;118(24):6136-43. doi: 10.1002/cncr.27676. Epub 2012 Jun 6. Cancer. 2012. PMID: 22674423 Free PMC article.

10

A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.

Beasley GM, Parsons C, Broadwater G, Selim MA, Marzban S, Abernethy AP, Salama AK, Eikman EA, Wong T, Zager JS, Tyler DS. Beasley GM, et al. Ann Surg. 2012 Aug;256(2):350-6. doi: 10.1097/SLA.0b013e318256d1f5. Ann Surg. 2012. PMID: 22691370 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

169 results

Search Page